Search

Implanting the enVista IOL

Eduardo Ligabue

Show Description +

The enVista (Bausch + Lomb, Rochester, New York) is the first hydrophobic acrylic IOL to receive the FDA labeling claim of being 100% glistening-free. This lens combines the company's aspheric, aberration-free Advanced Optics technology with a new glistening-free material. It is intended to minimize posterior capsular opacification.

Posted: 10/31/2011

Up Next

Management of Dislocated Posterior Chamber IOL

Management of Dislocated Posterior Chamber IOL

Altan A. Ozcan, MD

Posterior Lamellar Keratoplasty and Dislocated IOL

Posterior Lamellar Keratoplasty and Dislocated IOL

Ozana Moraru, MD

Scleral Fixation of Dislocated IOL Complex

Scleral Fixation of Dislocated IOL Complex

Majid Moshirfar, MD

PXF Dislocated IOL, IOL Exchange with Gortex Sutured IOL

PXF Dislocated IOL, IOL Exchange with Gortex Sutured IOL

Michael Patterson, DO

Refixation of a Dislocated Gortex Sutured Akreos IOL

Refixation of a Dislocated Gortex Sutured Akreos IOL

Jason N. Crosson, MD, Michael A. Albert MD

Dislocated IOL to Glued IOL

Dislocated IOL to Glued IOL

Michael Patterson, DO

Bubble Bubble Toil and Trouble

Bubble Bubble Toil and Trouble

Jason Jones, MD

Phacoemulsification Hard Cataract With Lens Coloboma

Phacoemulsification Hard Cataract With Lens Coloboma

Maneesh Bapaye, MD

Phaco Debulk Chop for Dense Cataracts

Phaco Debulk Chop for Dense Cataracts

Iqbal "Ike" K. Ahmed, MD, FRCSC

My Technique for Modern ECCE

My Technique for Modern ECCE

Ashraf Armia, MD

Implanting the enVista IOL

Eduardo Ligabue

The enVista (Bausch + Lomb, Rochester, New York) is the first hydrophobic acrylic IOL to receive the FDA labeling claim of being 100% glistening-free. This lens combines the company's aspheric, aberration-free Advanced Optics technology with a new glistening-free material. It is intended to minimize posterior capsular opacification.

Posted: 10/31/2011

Please log in to leave a comment.

More in Cataract

Challenging Cases Made Routine

Challenging Cases Made Routine

Michael D. Greenwood, MD

Cataract Surgery Under More Physiologic Conditions

Cataract Surgery Under More Physiologic Conditions

Matthew P. Rauen, MD

Real Application of UNITY® 4D Phaco Technology

Real Application of UNITY® 4D Phaco Technology

Alan R. Faulkner, MD

Decreasing the Medication Burden With iDose TR

Decreasing the Medication Burden With iDose TR

John P. Berdahl, MD; Natalia Morales, MD; and Justin Schweitzer, OD, FAAO